HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Complications of major lung resections by video-assisted thoracoscopic surgery].

Abstract
Lobectomy by video-assisted thoracoscopic surgery (VATS) is gradually being performed more frequently because of advantages regarding pain and pulmonary function. Complications sometimes occur during or after VATS lobectomy. The purpose of this study was to analyze the incidence and the causes of the complications. From 1997 to 2003, 185 patients underwent VATS lobectomies. Selected diseases for this approach included primary lung cancer (n = 172), metastatic lung cancer (n = 7), benign lung tumors (n = 3) and lung sequestration (n = 3). The VATS approach was converted to open thoracotomy in 15 (8.1%) of 185 patients because of bleeding (n = 8), dense hilar adenopathy (DHA, n = 3), local extent of disease (n = 3) of intraoperative cardiac trouble (n = 1). Intraoperative complications involved injury to a blood vessel (n = 21), stapling failure (n = 15), lung injury (n = 7), nerve injury (n = 3), and others. Predictive factors for injury to pulmonary arteries was DHA (OR 37.0, p < 0.0001). Postoperative surgical death occurred in 2 patients due to pneumonia. Postoperative morbidity was 22.9%. A surgical operation without any good direct or thoracoscopic view or the use of a thoracoscopic tool without knowledge of the directions on its use should be avoided. The VATS approach should be replaced by open thoracotomy if there are DHA.
AuthorsA Watanabe, H Osawa, T Watanabe, T Mawatari, Y Ichimiya, N Takahashi, T Abe
JournalKyobu geka. The Japanese journal of thoracic surgery (Kyobu Geka) Vol. 56 Issue 11 Pg. 943-8 (Oct 2003) ISSN: 0021-5252 [Print] Japan
PMID14579698 (Publication Type: English Abstract, Journal Article, Review)
Topics
  • Humans
  • Intraoperative Complications
  • Lung Injury
  • Lung Neoplasms (surgery)
  • Pneumonectomy (methods)
  • Postoperative Complications
  • Pulmonary Artery (injuries)
  • Thoracic Surgery, Video-Assisted (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: